Status:
RECRUITING
HighCycle Study: Effect of Acetazolamide on Sleep Disordered Breathing in Women Compared to Men
Lead Sponsor:
University of Zurich
Collaborating Sponsors:
National Center of Cardiology and Internal Medicine named after academician M.Mirrakhimov
University Hospital Heidelberg
Conditions:
Sleep-Disordered Breathing
Eligibility:
All Genders
18-44 years
Phase:
PHASE4
Brief Summary
Randomized clinical trial evaluating the effect of acetazolamide on sleep disordered breathing in women compared to men travelling to 3600 m.
Eligibility Criteria
Inclusion
- Healthy, non-smoking men and women, age 18-44 years, without any diseases and need of regular medication (including oral contraceptives).
- BMI \>18 kg/m2 and \<30 kg/m2
- Born, raised and currently living at altitudes \<1000 m
- Written informed consent
- Premenopausal women with an eumenorrheic cycle
Exclusion
- Other types of contraceptvies (hormonal intrauterine device, vaginal ring, subcutaneous injections or implants, among others)
- Pregnancy or nursing
- Anaemic (haemoglobin concentration \<10g/dl)
- Any altitude trip \<4 weks before the study
- Allergy to acetazolamide and other sulfonamides
Key Trial Info
Start Date :
July 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
270 Patients enrolled
Trial Details
Trial ID
NCT06498531
Start Date
July 15 2024
End Date
December 31 2025
Last Update
June 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Center for Cardiology and Internal Medicine
Bishkek, Gorod Bishkek, Kyrgyzstan, 720040